vanadates has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Danon, A; Rimon, G; Rosenstock, M | 1 |
Balabanova, L; Leffler, CW; Parfenova, H | 1 |
Chang, HC; Hung, WC; Pan, MR | 1 |
3 other study(ies) available for vanadates and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
Article | Year |
---|---|
Prostaglandin H synthase: protein synthesis-independent regulation in bovine aortic endothelial cells.
Topics: Aluminum Compounds; Animals; Aorta; Aspirin; Cattle; Cells, Cultured; Cycloheximide; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dactinomycin; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Fibroblast Growth Factor 2; Fluorides; Genistein; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanylyl Imidodiphosphate; Isoenzymes; Kinetics; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Sodium Fluoride; Sulfonamides; Time Factors; Vanadates | 1997 |
Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Animals, Newborn; Aorta; Cells, Cultured; Cerebral Cortex; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Membrane Proteins; Microcirculation; Muscle, Smooth, Vascular; Nitriles; Nitrobenzenes; Phenols; Phosphoproteins; Phosphorylation; Phosphotyrosine; Prostaglandin-Endoperoxide Synthases; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Sulfonamides; Swine; Tyrphostins; Vanadates | 1998 |
Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Dual Specificity Phosphatase 1; Dual Specificity Phosphatase 6; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Mitogen-Activated Protein Kinase Phosphatases; Nitrobenzenes; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins p21(ras); Serine; Sulfonamides; Vanadates | 2008 |